T2 Biosystems, Inc.·4

Mar 16, 12:41 PM ET

Pare Anthony 4

4 · T2 Biosystems, Inc. · Filed Mar 16, 2021

Insider Transaction Report

Form 4
Period: 2021-03-14
Pare Anthony
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-14+17,50041,232 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-03-1417,50035,000 total
    Common Stock (17,500 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Includes 15,206 shares acquired under the Issuer's employee stock purchase plan on May 15, 2020 (the "ESPP") and 3,949 shares acquired under the ESPP on November 15, 2020.
  • [F3]On March 14, 2020 the reporting person was granted 52,500 RSU's that vest in three equal annual installments beginning on March 14, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION